Competitive antagonism with para-aminobenzoic acid (PABA). Disrupts plate biosynthesis in sensitive organisms.
Therapeutic use
Adjunctive treatment of tuberculosis.
Pregnancy and lactiation implications
Use during pregnancy only if clearly needed. Not recommended during lactation.
Unlabeled use
Crohn’s disease.
Contraindications
Hypersensitivity to aminosalicylic acid or any component of the formulation.
Warnings and precautions
Increased risk of salicylate sensitivity in patients with sensitivity to tartrazine dyes, nasal polyps, or asthma. Use with caution in gastric ulcer, hepatic or renal impairment.